A Randomized, Open Label, Single Dose, Two Period, Crossover Study to Assess the Effect of Food on the Pharmacokinetics of RO5428029 Following Oral Administration in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2016
At a glance
- Drugs RO 5428029 (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Genentech; Roche
- 20 Aug 2012 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 01 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.